Recent advances in protein synthesis inhibitors

Area of Science:

• Microbiology and Molecular Biology
• Drug Discovery and Development

Background:

• Antibiotic resistance is a growing global health crisis, diminishing the effectiveness of current antimicrobial drugs.
• Bacterial translation is a promising target for novel antibiotics due to its essential role and differences from eukaryotic translation.

Purpose of the Study:

• To review recent advancements in targeting bacterial translation for antimicrobial therapy.
• To highlight structure-guided and context-aware strategies for developing new antibiotics.

Main Methods:

• Synthesis of recent high-resolution structural and biophysical studies on bacterial translation inhibitors.
• Analysis of inhibitors targeting initiation, elongation, termination, and recycling stages of translation.
• Investigation of bacterial quality-control pathways as additional intervention points.

Main Results:

• Structural and biophysical data have clarified ribosomal binding sites and mechanisms of action for various inhibitors.
• Previously unknown stage-specific activities and context-dependent mechanisms of action were uncovered.
• Bacterial quality-control pathways were identified as potential targets for orthogonal intervention.

Conclusions:

• Advances in understanding bacterial translation provide a strong foundation for structure-guided antibiotic design.
• Context-aware and hybrid/combination strategies are crucial for developing effective antimicrobial therapies against resistance.
• Targeting bacterial translation offers a viable path to expand and diversify the antibiotic pipeline.